Understanding the increasing incidence of neuroendocrine tumors

Authors: Pathak, Surabhi, Starr, Jason S., Halfdanarson, Thorvardur, Sonbol, Mohamad Bassam

Source: Expert review of endocrinology & metabolism. 18(5):377-385

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194131306.0x000001&indx=1&recIds=ETOCvdc_100194131306.0x000001

Targeting leukemia inhibitory factor in pancreatic adenocarcinoma

Authors: Wang, Jing, Karime, Christian, Majeed, Umair, Starr, Jason S., Borad, Mitesh J., Babiker, Hani M.

Source: Expert opinion on investigational drugs. 32(5):387-399

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185046811.0x000001&indx=1&recIds=ETOCvdc_100185046811.0x000001

Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms

Authors: Mosalem, Osama, Sonbol, Mohamad Bassam, Halfdanarson, Thorvardur R., Starr, Jason S.

Source: In Best Practice & Research Clinical Endocrinology & Metabolism September 2023 37(5)

Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes

Authors: Rutenberg, Michael S. ^*, Hoppe, Bradford S., Starr, Jason S., Awad, Ziad, Thomas, Mathew, Morris, Christopher G., Johnson, Perry, Henderson, Randal H., Jones, Jeremy C., MBBS, Bharatsinh Gharia, Bowers, Steven, Wolfsen, Herbert C., Krishnan, Sunil, Ko, Stephen J., Babiker, Hani M., Nichols, Romaine C., Jr

Source: In International Journal of Particle Therapy January 2023 9(3):18-29

Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS -Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.

Authors: Ahn, Daniel H., Ridinger, Maya, Cannon, Timothy L., Mendelsohn, Lawrence, Starr, Jason S., Hubbard, Joleen M., Kasi, Anup, Barzi, Afsaneh, Samuëlsz, Errin, Karki, Anju, Subramanian, Ramanand A., Yemane, Divora, Kim, Roy, Wu, Chu-Chiao, Croucher, Peter J.P., Smeal, Tod, Kabbinavar, Fairooz F., Lenz, Heinz-Josef

Source: Journal of Clinical Oncology; 3/1/2025, Vol. 43 Issue 7, p840-851, 22p

Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated (HRD) metastatic pancreatic cancer.

Authors: Jazieh, Khalid, Babiker, Hani M., Foster, Nathan R., Fruth, Briant, Carr, Ryan Michael, Alberts, Steven R, Conboy, Caitlin, Tran, Nguyen H., Hartgers, Mindy L., Halfdanarson, Thorvardur Ragnar, Starr, Jason S., Sonbol, Mohamad Bassam, Jones, Jeremy Clifton, Ahn, Daniel H., Kankeu Fonkoua, Lionel Aurelien, Wu, Christina, Pedersen, Katrina Sophia, Bekaii-Saab, Tanios S., McWilliams, Robert R.

Source: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p727-727, 121p

Immunotherapy outcomes in dMMR/MSI-H and/or TMB-H metastatic colorectal cancer (CRC) with peritoneal metastases (PM).

Authors: Mosalem, Osama M, Elhariri, Ahmed, Wiest, Nathaniel Edward, Kamatham, Saivaishnavi, Abdel-Razeq, Nayef Hikmat, Jones, Jeremy Clifton, Sonbol, Mohamad B., Jin, Zhaohui, Babiker, Hani M., Bekaii-Saab, Tanios S., Majeed, Umair, Starr, Jason S.

Source: Journal of Clinical Oncology; 2025 Supplement 4, Vol. 43, p163-163, 307p

Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma.

Authors: McKinley, Blake J, Coston, Tucker W, Starr, Jason S

Source: Oncologist; Jan2025, Vol. 30 Issue 1, p1-6, 6p

Subject Terms: PROTEINS, DRUG resistance in cancer cells, CARBOPLATIN, TREATMENT effectiveness, PANCREATIC tumors, CANCER chemotherapy, ETOPOSIDE, MONOCLONAL antibodies, NEUROENDOCRINE tumors, DISEASE complications, TUMOR classification, DISEASE progression

Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options

Authors: Ueberroth, Benjamin E., Liu, Alex J., Starr, Jason S., Hobday, Timothy J., Ashman, Jonathan B., Mishra, Nitin, Bekaii-Saab, Tanios S., Halfdanarson, Thorvardur R., Sonbol, M. Bassam

Source: In Clinical Colorectal Cancer June 2021 20(2):e139-e149

Outcomes on anti‐VEGFR‐2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma

Authors: Kankeu Fonkoua, Lionel A., Chakrabarti, Sakti, Sonbol, Mohamad B., Kasi, Pashtoon M., Starr, Jason S., Liu, Alex J., Nevala, Wendy K., Maus, Rachel L., Bois, Melanie C., Pitot, Henry C., Chandrasekharan, Chandrikha, Ross, Helen J., Wu, Tsung‐Teh, Graham, Rondell P., Villasboas, Jose C., Weiss, Matthias, Foster, Nathan R., Markovic, Svetomir N., Dong, Haidong, Yoon, Harry H.

Source: International journal of cancer. 149(2):378-386

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100121066944.0x000001&indx=1&recIds=ETOCvdc_100121066944.0x000001

Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms

Authors: Gile, Jennifer J., Liu, Alex J., McGarrah, Patrick W., Eiring, Rachel A., Hobday, Timothy J., Starr, Jason S., Sonbol, Mohamad B., Halfdanarson, Thorvardur R.

Source: Pancreas. 50(4):500-505

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182313345.0x000001&indx=1&recIds=ETOCvdc_100182313345.0x000001

Systematic Analysis of Extracting Data on Advance Directives from Patient Electronic Health Records (EHR) in Terminal Oncology Patients

Authors: Starr, Jason S., Skelton, William Paul, Rahmanian, Kiarash P., Guenther, Robert, Allen, William L., George, Thomas J., Moseley, Ray E.

Source: Journal of palliative care. 36(4):211-218

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN627554507&indx=1&recIds=ETOCRN627554507

Efficacy of first‐line checkpoint inhibitors in combination with chemotherapy in high‐grade extrapulmonary metastatic neuroendocrine carcinomas

Authors: Gile, Jennifer J., McGarrah, Patrick W., Leventakos, Konstantinos, Sonbol, Mohamad B., Starr, Jason S., Eiring, Rachel A., Hobday, Timothy J., Halfdanarson, Thorvardur R.

Source: Journal of neuroendocrinology. 35(5)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184424440.0x000001&indx=1&recIds=ETOCvdc_100184424440.0x000001

A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer.

Authors: Mosalem, Osama, Coston, Tucker W, Imperial, Robin, Mauer, Elizabeth, Thompson, Christopher, Yilma, Binyam, Bekaii-Saab, Tanios S, Stoppler, Melissa Conrad, Starr, Jason S

Source: Oncologist; Sep2024, Vol. 29 Issue 9, pe1224-e1227, 4p

Subject Terms: NUCLEAR proteins, CARRIER proteins, GENOMICS, RESEARCH funding, COLORECTAL cancer, CANCER patients, TUMOR markers, DNA, DESCRIPTIVE statistics, GENETIC variation, GENETIC mutation, TRANSFERASES, DISEASE susceptibility, PHENOTYPES, GENETIC testing, SEQUENCE analysis

Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma.

Authors: Klatte, Derk C.F., Starr, Jason S., Clift, Kristin E., Hardway, Heather D., van Hooft, Jeanin E., van Leerdam, Monique E., Potjer, Thomas P., Presutti, R. John, Riegert-Johnson, Douglas L., Wallace, Michael B., Bi, Yan

Source: JCO Oncology Practice; Aug2024, Vol. 20 Issue 8, p1081-1090, 10p

Subject Terms: ADENOCARCINOMA, MEDICAL protocols, T-test (Statistics), FISHER exact test, LOGISTIC regression analysis, RETROSPECTIVE studies, DESCRIPTIVE statistics, AGE distribution, GENETIC counseling, CHI-squared test, MULTIVARIATE analysis, PANCREATIC tumors, PRE-tests & post-tests, ODDS ratio, DUCTAL carcinoma, RESEARCH methodology, STATISTICS, CONFIDENCE intervals, GENETIC mutation, ONCOLOGISTS, SURVIVAL analysis (Biometry), DATA analysis software, GENETIC testing

Lutetium-177 DOTATATE Therapy and Cardiac Outcomes in Patients With Neuroendocrine Tumor and Cardiac Metastases

Authors: Scalia, Isabel G., Sonbol, Mohamad Bassam, Farina, Juan M., Pereyra, Milagros, Wang, Yuxiang, Bekaii-Saab, Tanios S., Yang, Ming, Connolly, Heidi M., Pellikka, Patricia A., Herrmann, Joerg, Halfdanarson, Thorvardur R., Starr, Jason S., Luis, Sushil Allen, Arsanjani, Reza, Ayoub, Chadi

Source: In JACC: CardioOncology December 2024 6(6):982-984

Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management

Authors: Franke, Aaron J., Parekh, Hiral, Starr, Jason S., Tan, Sanda A., Iqbal, Atif, George, Thomas J., Jr.

Source: In Clinical Colorectal Cancer March 2018 17(1):1-12

Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches

Authors: Franke, Aaron J, Skelton, William Paul, Starr, Jason S, Parekh, Hiral, Lee, James J, Overman, Michael J, Allegra, Carmen, George, Thomas J

Source: Journal of the National Cancer Institute. 111(11):1131-1141

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100096306282.0x000001&indx=1&recIds=ETOCvdc_100096306282.0x000001

Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

Authors: Uson Junior, Pedro Luiz Serrano, Majeed, Umair, Yin, Jun, Botrus, Gehan, Sonbol, Mohamad Bassam, Ahn, Daniel H., Starr, Jason S., Jones, Jeremy C., Babiker, Hani, Inabinett, Samantha R., Wylie, Natasha, Boyle, Ashton W.R., Bekaii-Saab, Tanios S., Gores, Gregory J., Smoot, Rory, Barrett, Michael, Nagalo, Bolni, Meurice, Nathalie, Elliott, Natalie, Petit, Joachim, Zhou, Yumei, Arora, Mansi, Dumbauld, Chelsae, Barro, Oumar, Baker, Alexander, Bogenberger, James, Buetow, Kenneth, Mansfield, Aaron, Mody, Kabir, Borad, Mitesh J.

Source: JCO precision oncology. 6(1)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100153536443.0x000001&indx=1&recIds=ETOCvdc_100153536443.0x000001

Clinical outcomes and molecular characteristics of patients with pancreatic acinar cell carcinoma.

Authors: Eslinger, Cody, Yee, Claire, Seddighzadeh, Bobak, Elsabbagh, Zaid, Pai, Rish, Hartley, Christopher P., Bekaii-Saab, Tanios S., Starr, Jason S., Halfdanarson, Thorvardur Ragnar, Sonbol, Bassam Bassam

Source: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p688-688, 117p